PSYENCE Trademark
Serial Number: 90732485
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 29 - Meats & Processed Foods
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Class 31 - Natural Agricultural Products
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Owner Contact Info
Legal Representation
Correspondence Address
Amy J Benjamin BENJAMIN LAW PC
111 EAST 14TH STREET
SUITE 469
NEW YORK, NY 10003
United States
Trademark Details
Filing Date
May 25, 2021
Registration Date
Not Registered
Published for Opposition
March 14, 2023
Goods & Services
Research and development in the fields of neurological conditions and their treatment and psychological conditions and their treatment; basic and clinical research in the fields of plant-based medicines and psychedelics; research and development in the field of holistic medicines, natural medicine, psychedelics and nootropics; research and development of treatments for mental health conditions; pharmaceutical research and development in the field of psilocybin; research and development in the field of psilocybin, holistic medicines, natural medicine, psychedelics and nootropics; research and development of psilocybin-based treatments for mental health conditions; scientific research in the nature of conducting clinical trials for others in the field of medicine and mental health; providing scientific research information in the field of psilocybin, psychoactive products, psychedelics and nootropics
Fresh edible fungi; fresh edible mushrooms; fresh mushrooms; unprocessed mushrooms
Anti-epileptic pharmaceutical preparations; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the relief of pain; preparations for the treatment of mental health disorders; pharmaceutical preparations and herbal supplements for enhancing mental health; pharmaceutical preparations, namely cognitive enhancers for the treatment of mental health disorders; herbal supplements, namely cognitive enhancers; dietary supplements for enhancing mental health, and for the treatment of mental health disorders; dietary and nutritional supplements for alleviating symptoms experienced in the palliative care setting, namely, nausea, anorexia, cachexia, severe intractable pain, severe depressed mood, and insomnia; plant-based supplements for aiding general health, well-being and cognitive function
Dried edible fungi; dried edible mushrooms; dried edible mushrooms; edible fungi oils not containing psilocybin or psilocin, fungal extracts for use as ingredients of nutritional supplements; fruit jellies not being confectionary